In silico bioprospecting of taraxerol as a main protease inhibitor of SARS-CoV-2 to develop therapy against COVID-19

Abstract

COVID-19 was caused by a novel coronavirus known as SARS-CoV-2. The COVID-19 disease outbreak has been avowed as a global pandemic by the World Health Organization at the end of March 2020. It leads to the global economic crash, resulting in the starvation of a large population belonging to economically backward countries. Hence, the development of an alternative medicine along with the vaccine is of the utmost importance for the management of COVID-19. Therefore, screening of several herbal leads was performed to explore their potential against SARS-CoV-2. Furthermore, viral main protease was selected as a key enzyme for performing the study. Various computational approaches, including molecular docking simulation, were used in the current study to find potential inhibitors of viral main protease from a library of 150 herbal leads. Toxicity and ADME prediction of selected molecules were also analysed by Osiris molecular property explorer software. Molecular dynamic simulation of the top 10 docked herbal leads was analysed for stability using 100 ns. Taraxerol (−10.17 kcal/mol), diosgenin (10.12 kcal/mol), amyrin (−9.56 kcal/mol), and asiaticoside (−9.54 kcal/mol) were among the top four herbal leads with the highest binding affinity with the main protease enzyme. Thus, taraxerol was found to be an effective drug candidate against the main protease enzyme for the management of COVID-19. Furthermore, its clinical effect and safety profile need to be established through an in vivo model. Supplementary information The online version contains supplementary material available at 10.1007/s11224-022-01943-x.

Computational Bioprospecting Guggulsterone against ADP Ribose Phosphatase of SARS-CoV-2

“…The study of molecular interactions between pivotal viral target proteins critical for the virus’s infectious nature and repurposed, clinically-approved medications may increase their application potential [ 39 ]. In silico drug repurposing can be utilized to identify and establish new therapeutic applications of existing drugs [ 11 , 19 , 20 , 21 , 22 ]. Drug repurposing and repositioning approaches are now frequently used to develop successful novel medicines for various conditions using drugs already used in the clinic.…”

“…The docking protocols incorporated in the ongoing research work were validated using ligand overlay methodology. The docked conformation should be perfectly inlaid over the crystallized reference conformation of the ligand [ 22 ].…”

“…To examine, integrate, and regulate considerable information produced from experimental data, in silico approaches are used. Computational drug screening provides a systematic and rational approach for the evaluation of therapeutic possibilities within traditional medications [ 21 , 22 , 23 , 24 ]. In this study, an integrated molecular docking simulation-based screening of herbal compounds was performed to identify potential leading compounds that could inhibit the SARS-CoV-2 ARP enzyme and possibly prevent its replication.…”

Investigation of Antiviral Potential of Food Carotenoids and Apocarotenoids against RNA-dependent RNA Polymerase of Hepatitis C Virus

“…Therefore, NPT ensemble condition was enabled during the simulation process and kept the temperature and pressure constant while allowing the system volume to change during the simulation. Desmond module of Schrödinger was used to perform MD simulation under energyminimized complex system and isosmotic environment was created to neutralize the existing charges by the addition of 0.15 M NaCl [30], [33].…”

Mechanistic Insight Hypolipidemic Potential of Ascorbic Acid: In-Silico Molecular Docking

“…The spacing between grids points can be adjusted with another thumbwheel, the value in the study taken is given in table 1. [10][11][12][13][14].…”